Skip to content

Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratoma (Retrospective Study)

Fecal Continence Outcomes and Quality of Life After Excision of Sacrococcygeal Teratma (Retrospective Study)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06133036
Enrollment
20
Registered
2023-11-15
Start date
2023-11-30
Completion date
2024-05-31
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sacrococcygeal Teratoma

Brief summary

Sacrococcygeal teratoma is one of the most common tumors that occur in the neonatal period. It presents either as a mass protruding from the sacrococcygeal region or as a pelviabdominal mass according to the type. Surgical excision is the main treatment, most masses are benign, however some are malignant and require radiotherapy or chemotherapy. Complications may occur due to pressure resulting from the tumor growth in the fetal period, or due to damage to important near tissues during surgical excision. Postoperative complications may be urinary as neurogenic bladder, Lower gastrointestinal as constipation, soiling or incontinence. In this work we study the outcomes of fecal continence through a questionnaire and its effect on the quality of life of the affected children.

Interventions

None listed

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* all patients with sacrococcygeal teratoma operated after july 2010 and older than 3 years old.

Exclusion criteria

* Patients lost to follow up before 6 months after surgery. * Patients with Currarino triad.

Design outcomes

Primary

MeasureTime frameDescription
Fecal continence6 monthsMeasured by Rintala continence score

Countries

Egypt

Contacts

Primary ContactMohamed K Khalil
mohamedkamal@med.sohag.edu.eg01028900808

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026